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Case Reportsthe descending aorta allowed right-to-left shunting and pre-
vented RV failure by relieving suprasystemic RV pressure
to a systemic pressure level. The position of the distal shunt
anastomosis distal to the subclavian artery would prevent a
desaturation of the head vessels and upper extremity. This
approach was combined with atrioseptectomy and bPAB
to protect the pulmonary circulation from volume overload.
Cardiopulmonary bypass was necessary for creation of the
neo–ductus arteriosus for this patient in a critical hemody-
namic situation. We therefore opted for a concomitant sur-
gical atrial septectomy during the procedure. Furthermore,
the result of a surgical atrioseptectomy under direct vision
is in our view the most reliable route for a longer-term non-
obstructive atrial septum.
At the same time that bPAB prevented active hypercircu-
lation, atrioseptectomy avoided passive pulmonary flow
obstruction. The measured pressure gradient of 55 mm Hg
across the bPAB highlights the fall in pulmonary vascular
resistance. The increase in systemic blood flow, however,
occurred at the expense of oxygen desaturation of the lower
part of the body, as described in patients with idiopathic PH
who were treated with a reversed Potts shunt.5From the Departments of Thoracic and Cardiovascular Surgerya and Cardiovascular
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e228 The Journal of Thoracic and Cardiovascular SurThe aim of our rescue procedure was to prevent further
episodes of cardiac decompensation caused by PH crises
and leading to resuscitation. Whether the decline in the pul-
monary vascular resistance would allow a successful heart
transplant, or even a biventricular repair, however, remains
unknown. Most probably, our strategy would allow a safer
waiting time for a combined heart and lung transplant in
future.
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The Gerbode defect, a direct communication between the
left ventricle (LV) and right atrium (RA), is rare and may
be either congenital or acquired. Acquired defects may bea result of complications of cardiac surgery, including
aortic, mitral, or tricuspid valve repair or replacement,
closure of a ventricular septal defect, endocarditis, or
trauma.1 Surgical correction has been the treatment of
choice, although a few case reports of transcatheter closure
have recently been published.2 We report a case of surgical
closure of an LV-RA shunt acquired after reoperative aortic
and mitral valve surgery for remote infective endocarditis
(IE), after a failed attempt to close the defect with the
transcatheter approach.CLINICAL SUMMARY
A 45-year-old man had undergone aortic valve (AV)
replacement and mitral valve (MV) repair for IE in 2006.
Recurrent IE in 2008 was treated with antibiotics. In
2013, he developed shortness of breath and was found to
have degeneration of his AV bioprosthesis and heart failure.
He underwent reoperation and had his aortic prosthesisgery c November 2014
FIGURE 1. A, Preoperative echocardiogram showing the Amplatzer device (arrow) used to cover the Gerbode defect with residual left to right shunt.
Amplatzer device in place before (B) and after (C) the aortic bioprosthesis removal. D, The defect in the anterior mitral leaflet (forceps). PAV, Prosthetic
aortic valve; TV, tricuspid valve; CS, coronary sinus; RCA, right coronary artery; LCA, left coronary artery; LVOT, left ventricular outflow tract.
Case Reportsreplaced with a no. 23 bioprosthetic valve. He developed
complete heart block and required a permanent pacemaker.
Within a few days he began to experience even worse
shortness of breath, and echocardiography revealed a very
large LV-RA fistula. Cardiac catheterization measured a
Qp/Qs ratio of 3:1. He developed progressive heart
failure with fluid retention and ascites. Closure with an
Amplatzer device was performed, but he continued to
experience worsening heart failure symptoms, fatigue and
ascites, intravascular hemolysis, and renal insufficiency.
An echocardiogram revealed that he still had a large
residual shunt. He became jaundiced and required repeated
large-volume paracentesis. He presented to our institution
in critically ill condition. An echocardiogram showed 3þ
mitral regurgitation (MR), 4þ tricuspid regurgitation, and
a large LV-RA shunt observed around the Amplatzer device
(Figure 1, A, and Video 1).
He underwent a third reoperation the next day. After
transecting the aorta above the sinotubular junction, the
aorta and RA wall were opened down to the Amplatzer
device. There was a huge hole between the RA and LV
below the bioprosthetic AV, with the Amplatzer device
sitting in it (Figure 1, B and C). There was also an anterior
mitral leaflet perforation (Figure 1, D). The aortic
bioprosthesis and Amplatzer device were removed and
the anulus debrided. The MV perforation was closed
and the tricuspid valve repaired with an annuloplastyThe Journal of Thoracic and Carring. The aortic root was reconstructed with a no. 24 aortic
allograft. The patient’s postoperative course was
uneventful, and follow-up echocardiogram demonstrated
a well-seated allograft without regurgitation, competent
mitral and tricuspid valves, and no residual LV-RA shunt.
DISCUSSION
Acquired LV-RA communication (a Gerbode defect) is
rare and arises mostly from complications of endocarditis
and cardiac surgery. Most defects are small and caused by
aortic or tricuspid valve sutures. Reoperations have also
been reported as a risk factor.1 If significant, surgical
correction has been the treatment of choice, although the
procedure carries high risk.1 The surgical approach is best
accomplished with a combined aortic/atrial approach,
which allows for visualization of both ends of the fistula
and the subsequent repair.
Increasing experience with transcatheter devices has
resulted in nearly one-third of acquired LV-RA shunts in Eu-
rope being closed percutaneously during the last decade.1,2
Devices have also been reported to cause erosion of the
aortic or atrial wall, resulting in fistulas.3,4 The perforation
in the base of the anterior mitral leaflet was in a position
that suggested erosion as a possible cause. Our patient’s
LV-RA defect was below the aortic prosthesis, suggesting
dehiscence of AV sutures placed at the entry of a pseudoa-
neurysm rupturing postoperatively into the RA.diovascular Surgery c Volume 148, Number 5 e229
Case ReportsWhen recognized postoperatively, the patient’s past
history of IE, 2 cardiac operations, and poor clinical
condition suggested that another reoperation would be
high risk, which led to the decision to close the fistula
with an Amplatzer device. Failure to close the shunt
percutaneously worsened his heart failure and resulted in
ascites, intravascular hemolysis, jaundice, and renal failure.
Successful cases of transcatheter closure of acquired
LV-RA fistulas have been reported,2 and device closure
was a reasonable option in this patient, although long-
term results are unknown. In our case, however, when the
device closure had failed and the patient’s heart failure
worsened, there was little excuse for not referring
this young man early to a center with more experience
performing complex reoperations.From the Thoracic Surgery Department, MDAnderson Cancer Center, Houston, Tex.
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e230 The Journal of Thoracic and Cardiovascular SurIn conclusion, transcatheter device closure of acquired
LV-RA fistulas can be justified and attempted, but if
unsuccessful, surgery should be reconsidered early, before
the patient becomes inoperable with multiorgan failure.References
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1495-8.Sternal metastasis of renal cell carcinoma: The role
of metastasectomyNaruhiko Ikoma, MD, and Ara Vaporciyan, MD, Houston, TexSternal metastasis of renal cell carcinoma (RCC) has rarely
been reported in the literature.1 This case series describes
the presentation and management of 3 patients with isolated
sternal metastasis of RCC treated with sternectomy with
curative intent.
CLINICAL SUMMARIES
Patient 1
A 40-year-old man was seen in April 2004 with an
enlarging sternal mass. Computed tomography revealed a
lytic lesion involving the entire manubrium and a mass in
the left kidney. Biopsy of the renal mass revealed an unclas-
sified RCC. Despite chemotherapy, the disease progressed.
In October 2004, the patient underwent en bloc chest wall
resection of a portion of the sternum, both clavicular heads,
and the medial first and second ribs. Reconstruction was
performed with Prolene mesh (Ethicon, Inc, Somerville,
NJ) and a left pectoralis major muscle flap. The pathology
report indicated an 8.5 3 6.5 3 6.0-cm metastatic RCC.In December 2004, left radical nephrectomy was per-
formed, and the pathology report revealed a 6.5-cm unclas-
sified RCC (Fuhrman nuclear grade 3) with invasion into
the perinephric adipose tissue and vascular lymphatic
spaces. In July 2007, brain and rib metastases were discov-
ered. The patient underwent stereotactic radiosurgery and
several craniotomies, followed by chemotherapy; however,
the disease progressed, and the patient died in April 2011.
Patient 2
A 60-year-old man was seen with an enlarging sternal
mass in February 2013. Biopsy revealed metastatic RCC,
and computed tomography revealed a right kidney tumor.
A right radical nephrectomy was performed in May 2013.
The histopathologic diagnosis was clear cell RCC
(Fuhrman nuclear grade 3). Because of the large size of
the sternal metastasis, the patient underwent adjuvant
chemotherapy, to which there was partial response. In
October 2013, the patient underwent total sternectomy
and reconstruction with GORE-TEX mesh (W. L. Gore &
Associates, Flagstaff, Ariz), titanium sternal bars, bilateral
pectoralis major flaps, and pedicled right rectus abdominis
muscle flap. The pathology report of the sternal lesion re-
vealed an 8.5 3 7.3-cm metastatic RCC.
Patient 3
A 47-year-old man was seen with a painful mass at the
medial border of his left clavicle. Biopsy in Novembergery c November 2014
